Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N2BP
|
|||
Former ID |
DNC008278
|
|||
Drug Name |
2,2-bis-(3-fluorophenyl)-2-phenylacetamide
|
|||
Synonyms |
CHEMBL261828; SCHEMBL13950934
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H15F2NO
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C(C2=CC(=CC=C2)F)(C3=CC(=CC=C3)F)C(=O)N
|
|||
InChI |
1S/C20H15F2NO/c21-17-10-4-8-15(12-17)20(19(23)24,14-6-2-1-3-7-14)16-9-5-11-18(22)13-16/h1-13H,(H2,23,24)
|
|||
InChIKey |
WBCHZEIUTRPOCM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Calcium-activated potassium channel (KCN) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem. 2008 Feb 28;51(4):976-82. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.